Posts Tagged ‘Biotech’
Votes are open for the TOP 100 Swiss Startups!
What is your favorite swiss startup? Every year the TOP 100 Swiss Startup Award showcases the 100 most innovative and promising Swiss startups. 438 Swiss deeptech startups have been featured in the ranking over the past decade. So far, they have created 11100 jobs and raised CHF 6.1 billion. In 2022, 269 Life Sciences…
Read MorePr. Antoine Geissbuhler is the new BioAlps’ President
A Digital Health specialist to promote the Swiss Health Valley and the number one and most diversified Life Sciences Cluster in Europe After a selection process of several months, BioAlps’ Executive Committee identified a strong candidate to take over the role of Mr Claude Clément as President of the BioAlps Association. On Thursday 19…
Read MoreAlithea Genomics closes a CHF 1 million seed round
Alithea Genomics, a Lausanne-based fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with the participation of Swiss-based private investors. Alithea has developed a proprietary technology called Bulk RNA Barcoding and sequencing (BRB-seq), which enables the preparation…
Read MoreKodiak Sciences and Lonza open a new facility in Visp
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat retinal diseases, and Lonza announced on 17 May 2022 the opening of a new, custom-built, bioconjugation facility within Lonza’s Ibex® Dedicate manufacturing complex in Visp, Switzerland. The facility will play a key role in the scaled…
Read MoreHansjörg Wyss, the life sciences philanthropist
On 17 May 2022, Hansjörg Wyss received the Gallatin Award from the Swiss American Chamber of Commerce for his great commitment to the science landscape in Switzerland. “The ongoing commitment of Hansjörg Wyss and his Foundation to support groundbreaking research in Switzerland and elsewhere is more than a gift: it is a strong symbol…
Read MoreHemostOD creates ex vivo blood platelets
HemostOD has developed a solution for ex vivo on-demand production of blood platelets. The company just received a CHF 100 000 Tech Seed loan from the Foundation for Technological Innovation (FIT). Worldwide, 10 million platelet concentrates are transfused each year. Platelets are small blood cells whose function is to stop bleeding. Today, patients can only…
Read MoreSwiss biotech companies attracted investments of $3.33 billion in 2021
Last year was ‘the second best year in terms of fundraising’, according to the Swiss Biotech Association. The sector benefited from a “still strong” international contribution. Of the $3.33 billion, $2.51 billion was invested in listed companies, including Sophia Genetics in Lausanne, with $234 million following its initial public offering (IPO) and its follow-up,…
Read MorePodcast: Claude Clément
BioAlps President, Claude Clément, discusses career choices and how to lead innovation in the healthcare industry in the podcast What To Do Next? Claude Clément first worked in R&D for the watch industry (Swatch Group🇨🇭), then entered the world of medical technologies by heading the diversification activities of Swatch in the field of wearable programmable drug delivery…
Read MoreMerck Serono improves quality control with IA
Artificial Intelligence helps to assess the severity of a manufacturing incident in a medicine production unit In any factory, every day, a problem occurs. But when it happens at a site that manufactures cancer or multiple sclerosis drugs, the consequences can turn into a catastrophe. In order to make the right decisions as quickly…
Read MoreEUR 1 million Eurostars grant for Limula and Ceidos
The two swiss biotech startups signed an agreement with Stemmatters in Portugal. They received a Eurostars grant of EUR 1.14 million to merge their expertise to develop platforms for the automated production of cell and gene therapy products. Chimeric antigen receptor (CAR) T-cell therapies have shown exceptional clinical efficacy for the treatment of multiple…
Read More